Increasing Regulatory Controls And Patent Expiries Will Erode Value
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 19 Analysts
Published
28 Jul 25
Updated
10 Aug 25
AnalystLowTarget's Fair Value
UK£109.56
5.7% overvalued intrinsic discount10 Aug
UK£115.86
1Y
-12.0%7D
5.8%